Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Identifieur interne : 000D69 ( Ncbi/Curation ); précédent : 000D68; suivant : 000D70Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Auteurs : Ethan B. RussoSource :
- British Journal of Pharmacology [ 0007-1188 ] ; 2011.
Abstract
Tetrahydrocannabinol (THC) has been the primary focus of cannabis research since 1964, when Raphael Mechoulam isolated and synthesized it. More recently, the synergistic contributions of cannabidiol to cannabis pharmacology and analgesia have been scientifically demonstrated. Other phytocannabinoids, including tetrahydrocannabivarin, cannabigerol and cannabichromene, exert additional effects of therapeutic interest. Innovative conventional plant breeding has yielded cannabis chemotypes expressing high titres of each component for future study. This review will explore another echelon of phytotherapeutic agents, the cannabis terpenoids: limonene, myrcene, α-pinene, linalool, β-caryophyllene, caryophyllene oxide, nerolidol and phytol. Terpenoids share a precursor with phytocannabinoids, and are all flavour and fragrance components common to human diets that have been designated Generally Recognized as Safe by the US Food and Drug Administration and other regulatory agencies. Terpenoids are quite potent, and affect animal and even human behaviour when inhaled from ambient air at serum levels in the single digits ng·mL−1. They display unique therapeutic effects that may contribute meaningfully to the entourage effects of cannabis-based medicinal extracts. Particular focus will be placed on phytocannabinoid-terpenoid interactions that could produce synergy with respect to treatment of pain, inflammation, depression, anxiety, addiction, epilepsy, cancer, fungal and bacterial infections (including methicillin-resistant
This article is part of a themed issue on Cannabinoids in Biology and Medicine. To view the other articles in this issue visit
Url:
DOI: 10.1111/j.1476-5381.2011.01238.x
PubMed: 21749363
PubMed Central: 3165946
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001335
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :001333
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000E08
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000D69
Links to Exploration step
PMC:3165946Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects</title>
<author><name sortKey="Russo, Ethan B" sort="Russo, Ethan B" uniqKey="Russo E" first="Ethan B" last="Russo">Ethan B. Russo</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">21749363</idno>
<idno type="pmc">3165946</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946</idno>
<idno type="RBID">PMC:3165946</idno>
<idno type="doi">10.1111/j.1476-5381.2011.01238.x</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">001335</idno>
<idno type="wicri:Area/Pmc/Curation">001333</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000E08</idno>
<idno type="wicri:Area/Ncbi/Merge">000D69</idno>
<idno type="wicri:Area/Ncbi/Curation">000D69</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects</title>
<author><name sortKey="Russo, Ethan B" sort="Russo, Ethan B" uniqKey="Russo E" first="Ethan B" last="Russo">Ethan B. Russo</name>
</author>
</analytic>
<series><title level="j">British Journal of Pharmacology</title>
<idno type="ISSN">0007-1188</idno>
<idno type="eISSN">1476-5381</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Tetrahydrocannabinol (THC) has been the primary focus of cannabis research since 1964, when Raphael Mechoulam isolated and synthesized it. More recently, the synergistic contributions of cannabidiol to cannabis pharmacology and analgesia have been scientifically demonstrated. Other phytocannabinoids, including tetrahydrocannabivarin, cannabigerol and cannabichromene, exert additional effects of therapeutic interest. Innovative conventional plant breeding has yielded cannabis chemotypes expressing high titres of each component for future study. This review will explore another echelon of phytotherapeutic agents, the cannabis terpenoids: limonene, myrcene, α-pinene, linalool, β-caryophyllene, caryophyllene oxide, nerolidol and phytol. Terpenoids share a precursor with phytocannabinoids, and are all flavour and fragrance components common to human diets that have been designated Generally Recognized as Safe by the US Food and Drug Administration and other regulatory agencies. Terpenoids are quite potent, and affect animal and even human behaviour when inhaled from ambient air at serum levels in the single digits ng·mL<sup>−1</sup>
. They display unique therapeutic effects that may contribute meaningfully to the entourage effects of cannabis-based medicinal extracts. Particular focus will be placed on phytocannabinoid-terpenoid interactions that could produce synergy with respect to treatment of pain, inflammation, depression, anxiety, addiction, epilepsy, cancer, fungal and bacterial infections (including methicillin-resistant <italic>Staphylococcus aureus</italic>
). Scientific evidence is presented for non-cannabinoid plant components as putative antidotes to intoxicating effects of THC that could increase its therapeutic index. Methods for investigating entourage effects in future experiments will be proposed. Phytocannabinoid-terpenoid synergy, if proven, increases the likelihood that an extensive pipeline of new therapeutic products is possible from this venerable plant.</p>
<sec><title>LINKED ARTICLES</title>
<p>This article is part of a themed issue on Cannabinoids in Biology and Medicine. To view the other articles in this issue visit <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/bph.2011.163.issue-7">http://dx.doi.org/10.1111/bph.2011.163.issue-7</ext-link>
</p>
</sec>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Bois/explor/OrangerV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D69 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000D69 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Bois |area= OrangerV1 |flux= Ncbi |étape= Curation |type= RBID |clé= PMC:3165946 |texte= Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:21749363" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a OrangerV1
This area was generated with Dilib version V0.6.25. |